Where we come from
Although firmly rooted in Germany, today we are very much a growing global business. An integrated research and development company, we have an enviable track record of bringing effective pain treatments and state-of-the-art technologies to patients. Our high level of investment in R&D is testament to our unwavering commitment to innovation.
Grünenthal Pharma Ltd., Ireland, a wholly owned subsidiary of Grünenthal GmbH, was established in 2005. With headquarters in Dublin, the company distributes and markets pain and anti-infective products under an exclusive distribution agreement with Grünenthal GmbH.
Grünenthal Pharma Limited markets Qutenza, Zydol® (tramadol HCI), Zydol SR®, Ixprim®, Ixprim Effervescent®, Versatis®, Palexia Film Coated Tablets® and Palexia SR®.